Literature DB >> 19826576

Malaria and pregnancy: a global health perspective.

Julianna Schantz-Dunn, Nawal M Nour.   

Abstract

Malaria, a parasitic infection transmitted by mosquitoes, is one of the most devastating infectious diseases, killing more than 1 million people annually. Pregnant women, children, and immunocompromised individuals have the highest morbidity and mortality, and Africa bears the heaviest burden. The World Health Organization defines malaria as a disease of poverty caused by poverty. Pregnant women infected with malaria usually have more severe symptoms and outcomes, with higher rates of miscarriage, intrauterine demise, premature delivery, low-birth-weight neonates, and neonatal death. They are also at a higher risk for severe anemia and maternal death. Malaria can be prevented with appropriate drugs, bed nets treated with insecticide, and effective educational outreach programs.

Entities:  

Keywords:  Malaria, immunocompromised host; Malaria, neonates; Malaria, pregnancy; Plasmodium falciparum

Year:  2009        PMID: 19826576      PMCID: PMC2760896     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN: 1941-2797


  14 in total

Review 1.  Epidemiology and burden of malaria in pregnancy.

Authors:  Meghna Desai; Feiko O ter Kuile; François Nosten; Rose McGready; Kwame Asamoa; Bernard Brabin; Robert D Newman
Journal:  Lancet Infect Dis       Date:  2007-02       Impact factor: 25.071

Review 2.  Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa.

Authors:  Paula E Brentlinger; Christopher B Behrens; Mark A Micek
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

Review 3.  Drugs for preventing malaria in pregnant women.

Authors:  P Garner; A M Gülmezoglu
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

4.  Malaria in pregnant woman masquerading as HELLP syndrome.

Authors:  Guillaume Ducarme; Claire Thuillier; Anne Wernet; Claire Bellier; Dominique Luton
Journal:  Am J Perinatol       Date:  2009-07-22       Impact factor: 1.862

5.  Efficacy of intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine in preventing anaemia in pregnancy among Nigerian women.

Authors:  O O Asa; A A Onayade; A O Fatusi; K T Ijadunola; T C Abiona
Journal:  Matern Child Health J       Date:  2008-02-15

6.  Pregnancy-associated malaria in a rural community of ghana.

Authors:  Mf Ofori; E Ansah; I Agyepong; D Ofori-Adjei; L Hviid; Bd Akanmori
Journal:  Ghana Med J       Date:  2009-03

Review 7.  Drugs for treating uncomplicated malaria in pregnant women.

Authors:  Lois C Orton; Aika A A Omari
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 8.  Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.

Authors:  Philip J Peters; Michael C Thigpen; Monica E Parise; Robert D Newman
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 9.  Placental malaria, maternal HIV infection and infant morbidity.

Authors:  V Briand; C Badaut; M Cot
Journal:  Ann Trop Paediatr       Date:  2009-06

10.  Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.

Authors:  Catherine O Falade; Bidemi O Yusuf; Francis F Fadero; Olugbenga A Mokuolu; Davidson H Hamer; Lateef A Salako
Journal:  Malar J       Date:  2007-07-06       Impact factor: 2.979

View more
  86 in total

1.  High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine.

Authors:  Olusola Ojurongbe; Christian N Nguetse; Samuel A Fayemiwo; Catherine O Falade; Taiwo A Ojurongbe; Bolaji N Thomas; Christian G Meyer; Thirumalaisamy P Velavan
Journal:  Pathog Glob Health       Date:  2018-01-10       Impact factor: 2.894

Review 2.  Recent trends on hydrogel based drug delivery systems for infectious diseases.

Authors:  Arti Vashist; Ajeet Kaushik; Atul Vashist; Rahul Dev Jayant; Asahi Tomitaka; Sharif Ahmad; Y K Gupta; Madhavan Nair
Journal:  Biomater Sci       Date:  2016-10-18       Impact factor: 6.843

3.  Antiretrovirals in pregnancy: a note of caution.

Authors:  D Heather Watts; Lynne M Mofenson
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

Review 4.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

5.  Anti-infective use in children and pregnancy: current deficiencies and future challenges.

Authors:  Amanda Gwee; Noel Cranswick
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

Review 6.  Zika virus - reigniting the TORCH.

Authors:  Carolyn B Coyne; Helen M Lazear
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

7.  Maternal clinical findings in malaria in pregnancy in a region of northwestern Colombia.

Authors:  Juan Gabriel Piñeros; Alberto Tobon-Castaño; Gonzalo Alvarez; Carmencita Portilla; Silvia Blair
Journal:  Am J Trop Med Hyg       Date:  2013-07-29       Impact factor: 2.345

8.  Determinants of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women (IPTp-SP) in Mali, a household survey.

Authors:  Oumar Sangho; Moctar Tounkara; Lillian Joyce Whiting-Collins; Madeleine Beebe; Peter J Winch; Seydou Doumbia
Journal:  Malar J       Date:  2021-05-22       Impact factor: 2.979

9.  Addressing the Child and Maternal Mortality Crisis in Haiti through a Central Referral Hospital Providing Countrywide Care.

Authors:  Lee D Jacobs; Thomas M Judd; Zulfiqar A Bhutta
Journal:  Perm J       Date:  2016-02-25

10.  Decomposition of socioeconomic inequalities in the uptake of intermittent preventive treatment of malaria in pregnancy in Nigeria: evidence from Demographic Health Survey.

Authors:  Chijioke Ifeanyi Okoli; Mohammad Hajizadeh; Mohammad Mafizur Rahman; Rasheda Khanam
Journal:  Malar J       Date:  2021-07-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.